In patients with GHD, GH therapy can improve body composition, reduce fat mass, increase lean body mass, and improve lipid profiles, highlighting the therapeutic potential of targeting GHRH/GH pathways in metabolic disorders [143]. The gene discussed is GH1; the disease is metabolic disease.